In this capacity and with overexpression in cancer, MUC1-C functions as an oncoprotein that interacts with (i) receptor tyrosine kinases (RTKs) at the cell surface and (ii) certain transcription factors, such as β-catenin/TCF4 and NF-κB p65, in the nucleus29–31. This evidence concerns the gene NFKB1 and cancer.